Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.
Information We Collect
Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.
Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.
On our registration screens you will also find a Burning Question field. Submission of a Burning Question is completely voluntary. By submitting a Burning Question, you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:
Restrict or inhibit any other user from using the listserve
Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
Post or transmit any information, software or other material which contains a virus or other harmful component
Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing
By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.
Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.
Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.
Uses We Make of Information
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.
Protection of Information
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.
Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact firstname.lastname@example.org.
Revision date: This policy was last updated on September 30, 2003.
âNew and Emerging Agents in the Treatment of Metastatic Melanomaâ is a new chapter in Tumor Immunology and Immunotherapy Living Medical Textbook: Metastatic Melanoma Edition. Editor-in-Chief Jeffrey S. Weber, MD, PhD, takes you on a quick tour of key emerging monoclonal antibodies, cytokines and growth factors, and cancer vaccines that are being developed for the treatment of melanoma. top
The goal of this CME/CE activity is to examine the role of the immune system in fighting cancer and potential strategies for re-educating the immune system to break tolerance of "self" antigens that mask tumors from cellular immunity.
This CME/CE activity is designed for medical oncologists, dermatologists, primary care providers (internists and family practice practitioners) nurses/nurse practitioners, pharmacists, and physician assistants who interact with and/or treat patients with melanoma or other solid tumors.
Describe the cells of the innate and adaptive immune system and their usual functions in fighting infection, based on current research and the evolving state of the science.
Discuss the basic immunologic features of tumor cells to show understanding of why these cells are potential targets of the immune system.
Assess how tumor cells evade detection and destruction by T-cells to better identify opportunities for intervention in this process
Assess how secondary signals direct whether T-cells become activated, anergic, inhibited, or apoptotic in order to identify therapeutic targets for new immunotherapies in the treatment of cancer.
Evaluate the potential for therapeutic benefits of CTLA-4 blockade in patients with melanoma and prostate cancer based on currently available preclinical and clinical data.
Prepare strategies to manage side effects of CTLA-4 antibodies in patients with melanoma in order to reduce their impact on patient quality of life while maintaining therapeutic dosing.
Assess the rate of immune-related adverse events (IRAEs) in recent clinical trials of CTL-4 blockade in metastatic melanoma and prostate cancer and the association of these events with possible clinical benefit.